Impact of Ligand Size and Conjugation Chemistry on the Performance of Universal Chimeric Antigen Receptor T-Cells for Tumor Killing.
|
| Abstract |
All Universal Chimeric Antigen Receptor T-cells (UniCAR T-cells) are T-cells which have been engineered to recognize a haptenated ligand. Due to this feature, UniCAR T-cells have the potential to mediate a potent and selective tumor killing only in the presence of a haptenated tumor ligand, thus avoiding the long-lasting biocidal effects of conventional CAR T-cells. We have used fluorescein-labeled versions of small organic ligands and different antibody formats specific to carbonic anhydrase IX (a tumor-associated antigen) in order to assess whether the killing potential of UniCAR T-cells depended on the molecular features of the haptenated molecule. Both small molecule ligands and larger antibody fragments were potent in mediating tumor cell killing over a broad concentration range. Antibodies could be conveniently used both in IgG format and as smaller diabody fragments. Importantly, the use of site-specific chemical modification strategies for the antibody coupling to fluorescein led to a substantial improvement of tumor cell killing performance, compared to the random modification of primary amino groups on the antibody surface.
|
|---|---|
| Authors | Christian Pellegrino, Nicholas Favalli, Michael Sandholzer, Laura Volta, Gabriele Bassi, Jacopo Millul, Samuele Cazzamalli, Mattia Matasci, Alessandra Villa, Renier Myburgh, Markus G Manz, Dario Neri |
| Journal | Bioconjugate chemistry (Bioconjug Chem) Vol. 31 Issue 7 Pg. 1775-1783 (07 15 2020) ISSN: 1520-4812 [Electronic] United States |
| PMID | 32515934 (Publication Type: Journal Article) |
| Chemical References |
|
| Topics |
|
Join CureHunter, for free Research Interface BASIC access!
Realize the full power of the drug-disease research graph!